Abstract: A process for manufacturing a bellows, made of austenitic high-grade steel with high compressive strength and fatigue strength, forms a single-layer or multilayer sleeve into a bellows with hydraulic forming. The pressure resistance and fatigue strength are improved by the bellows being cleaned after the forming and by the bellows being exposed to a surrounding area containing carbon and/or nitrogen atoms at temperatures between 100° C. and 400° C., preferably 200° C. to 320° C. With this a hardening of the bellows takes place by means of the diffusing in of carbon and/or nitrogen atoms. A bellows made of austenitic high-grade steel with one or more layers created in this manner has the edge layer hardened by the incorporation of carbon and/or nitrogen atoms up to a hardening depth of at least 5% of the wall thickness.

Abstract: A process for manufacturing a bellows, made of austenitic high-grade steel with high compressive strength and fatigue strength, forms a single-layer or multilayer sleeve into a bellows with hydraulic forming. The pressure resistance and fatigue strength are improved by the bellows being cleaned after the forming and by the bellows being exposed to a surrounding area containing carbon and/or nitrogen atoms at temperatures between 100° C. and 400° C., preferably 200° C. to 320° C. With this a hardening of the bellows takes place by means of the diffusing in of carbon and/or nitrogen atoms. A bellows made of austenitic high-grade steel with one or more layers created in this manner has the edge layer hardened by the incorporation of carbon and/or nitrogen atoms up to a hardening depth of at least 5% of the wall thickness.

Abstract: The present invention relates to organic molecules capable of modulating, regulating and/or inhibiting protein kinase signal transduction. Such compounds are useful for the treatment of diseases related to unregulated protein kinase signal transduction, including cell proliferative diseases such as cancer, atherosclerosis, arthritis and restenosis and metabolic diseases such as diabetes. The present invention features indolinone compounds that potently inhibit protein kinases and related products and methods. Inhibitors specific to the FLK protein kinase can be obtained by adding chemical substituents to the 3-[(indole-3-yl)methylene]-2-indolinone, in particular at the 1? position of the indole ring. Indolinone compounds that specifically inhibit the FLK and platelet derived growth factor protein kinases can harbor a tetrahydroindole or cyclopentano-b-pyrrol moiety.